Works matching IS 13866346 AND DT 2019 AND VI 49 AND IP 10


Results: 20
    1

    Issue Information.

    Published in:
    Hepatology Research, 2019, v. 49, n. 10, p. 1089, doi. 10.1111/hepr.13441
    Publication type:
    Article
    2
    3
    4

    Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update.

    Published in:
    Hepatology Research, 2019, v. 49, n. 10, p. 1109, doi. 10.1111/hepr.13411
    By:
    • Kokudo, Norihiro;
    • Takemura, Nobuyuki;
    • Hasegawa, Kiyoshi;
    • Takayama, Tadatoshi;
    • Kubo, Shoji;
    • Shimada, Mitsuo;
    • Nagano, Hiroaki;
    • Hatano, Etsuro;
    • Izumi, Namiki;
    • Kaneko, Shuichi;
    • Kudo, Masatoshi;
    • Iijima, Hiroko;
    • Genda, Takuya;
    • Tateishi, Ryosuke;
    • Torimura, Takuji;
    • Igaki, Hiroshi;
    • Kobayashi, Satoshi;
    • Sakurai, Hideyuki;
    • Murakami, Takamichi;
    • Watadani, Takeyuki
    Publication type:
    Article
    5
    6
    7

    Assessing the risk of hepatocellular carcinoma by combining liver stiffness and the controlled attenuation parameter.

    Published in:
    Hepatology Research, 2019, v. 49, n. 10, p. 1207, doi. 10.1111/hepr.13391
    By:
    • Izumi, Takaaki;
    • Sho, Takuya;
    • Morikawa, Kenichi;
    • Shigesawa, Taku;
    • Suzuki, Kazuharu;
    • Nakamura, Akihisa;
    • Ohara, Masatsugu;
    • Kawagishi, Naoki;
    • Umemura, Machiko;
    • Shimazaki, Tomoe;
    • Kimura, Megumi;
    • Nakai, Masato;
    • Suda, Goki;
    • Natsuizaka, Mitsuteru;
    • Ogawa, Koji;
    • Kudo, Yusuke;
    • Nishida, Mutsumi;
    • Ono, Kota;
    • Baba, Masaru;
    • Furuya, Ken
    Publication type:
    Article
    8

    Hypozincemia is associated with human hepatocarcinogenesis in hepatitis C virus‐related liver cirrhosis.

    Published in:
    Hepatology Research, 2019, v. 49, n. 10, p. 1127, doi. 10.1111/hepr.13388
    By:
    • Shigefuku, Ryuta;
    • Iwasa, Motoh;
    • Katayama, Kazuhiro;
    • Eguchi, Akiko;
    • Kawaguchi, Takumi;
    • Shiraishi, Koichi;
    • Ito, Toshifumi;
    • Suzuki, Kazutomo;
    • Koreeda, Chizu;
    • Ohtake, Takaaki;
    • Tokumoto, Yoshio;
    • Endo, Ryujin;
    • Kawamura, Naohiro;
    • Shiraki, Makoto;
    • Habu, Daiki;
    • Sakai, Hironori;
    • Kato, Akinobu;
    • Nishiguchi, Shuhei;
    • Moriwaki, Hisataka;
    • Suzuki, Kazuyuki
    Publication type:
    Article
    9
    10
    11

    Combined effect of a farnesoid X receptor agonist and dipeptidyl peptidase‐4 inhibitor on hepatic fibrosis.

    Published in:
    Hepatology Research, 2019, v. 49, n. 10, p. 1147, doi. 10.1111/hepr.13385
    By:
    • Shimozato, Naotaka;
    • Namisaki, Tadashi;
    • Kaji, Kosuke;
    • Kitade, Mitsuteru;
    • Okura, Yasushi;
    • Sato, Shinya;
    • Moriya, Kei;
    • Seki, Kenichiro;
    • Kawaratani, Hideto;
    • Takaya, Hiroaki;
    • Sawada, Yasuhiko;
    • Saikawa, Soichiro;
    • Nakanishi, Keisuke;
    • Furukawa, Masanori;
    • Fujinaga, Yukihisa;
    • Kubo, Takuya;
    • Asada, Kiyoshi;
    • Kitagawa, Koh;
    • Tsuji, Yuki;
    • Kaya, Daisuke
    Publication type:
    Article
    12
    13
    14
    15
    16
    17

    Real‐world efficacy of elbasvir and grazoprevir for hepatitis C virus (genotype 1): A nationwide, multicenter study by the Japanese Red Cross Hospital Liver Study Group.

    Published in:
    Hepatology Research, 2019, v. 49, n. 10, p. 1114, doi. 10.1111/hepr.13362
    By:
    • Mashiba, Toshie;
    • Joko, Kouji;
    • Kurosaki, Masayuki;
    • Ochi, Hironori;
    • Hasebe, Chitomi;
    • Akahane, Takehiro;
    • Sohda, Tetsuro;
    • Tsuji, Keiji;
    • Mitsuda, Akeri;
    • Kimura, Hiroyuki;
    • Narita, Ryoichi;
    • Ogawa, Chikara;
    • Furuta, Koichiro;
    • Shigeno, Masaya;
    • Okushin, Hiroaki;
    • Ito, Hiroshi;
    • Kusakabe, Atsunori;
    • Satou, Takashi;
    • Kawanami, Chiharu;
    • Nakata, Ryo
    Publication type:
    Article
    18
    19
    20